AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new Northwestern Medicine study that tested six models developed by Meta, Google, ...

Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast ...

Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...

Intended to assist biopharma developers of companion assays, the partnership follows one for clinical trial support the firms announced last year.

A multicentre study found that an AI model using routine H&E pathology slides and clinicopathological data could estimate genomic recurrence risk and predict chemotherapy benefit in hormone ...

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...